Exploring the Use of Remimazolam (BYFAVO®) in Patients at High Risk for ERCP to Reduce Intraoperative Hypotension and Assess Safety and Efficacy: A Randomized Controlled Trial
Latest Information Update: 19 Feb 2024
At a glance
- Drugs Remimazolam (Primary)
- Indications Anaesthesia
- Focus Adverse reactions
- 19 Feb 2024 New trial record